Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...

Being a "Pawn Star" came in handy for Rick Harrison this month when he spotted a perfect ring to pop the question.

PepsiCo’s solid payout hike signals growth potential beyond 2025. See why PEP stock could offer a 40% total return through ...

Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...